Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23194481 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
Condition: Acute Coronary Syndrome
Interventions: Drug: Otamixaban;   Drug: Placebo (for Otamixaban);   Drug: UFH;   Drug: Placebo (for UFH);   Drug: Eptifibatide;   Drug: Placebo (for Eptifibatide)

Indicates status has not been verified in more than two years